GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Rite Aid Corp (OTCPK:RADCQ) » Definitions » EBIT

Rite Aid (Rite Aid) EBIT : $-1,392 Mil (TTM As of Aug. 2023)


View and export this data going back to 1970. Start your Free Trial

What is Rite Aid EBIT?

Rite Aid's earnings before interest and taxes (EBIT) for the three months ended in Aug. 2023 was $-945 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Aug. 2023 was $-1,392 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Rite Aid's annualized ROC % for the quarter that ended in Aug. 2023 was -22.70%. Rite Aid's annualized ROC (Joel Greenblatt) % for the quarter that ended in Aug. 2023 was -84.58%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Rite Aid's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Aug. 2023 was -21.42%.


Rite Aid EBIT Historical Data

The historical data trend for Rite Aid's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rite Aid EBIT Chart

Rite Aid Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -361.75 148.05 81.16 -350.66 -532.00

Rite Aid Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -266.79 -10.24 -196.40 -240.01 -945.03

Competitive Comparison of Rite Aid's EBIT

For the Pharmaceutical Retailers subindustry, Rite Aid's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rite Aid's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Rite Aid's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Rite Aid's EV-to-EBIT falls into.



Rite Aid EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1,392 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rite Aid  (OTCPK:RADCQ) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Rite Aid's annualized ROC % for the quarter that ended in Aug. 2023 is calculated as:

ROC % (Q: Aug. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: May. 2023 ) + Invested Capital (Q: Aug. 2023 ))/ count )
=-1451.48 * ( 1 - -0.23% )/( (5237.092 + 7582.888)/ 2 )
=-1454.818404/6409.99
=-22.70 %

where

Invested Capital(Q: May. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=7650.418 - 2277.799 - ( 135.527 - max(0, 2772.571 - 3649.463+135.527))
=5237.092

Invested Capital(Q: Aug. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=7125.952 - 2322.365 - ( 92.926 - max(0, 6517.954 - 3738.653+92.926))
=7582.888

Note: The Operating Income data used here is four times the quarterly (Aug. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Rite Aid's annualized ROC (Joel Greenblatt) % for the quarter that ended in Aug. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Aug. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: May. 2023  Q: Aug. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-3780.136/( ( (3349.65 + max(1236.137, 0)) + (3029.044 + max(1323.362, 0)) )/ 2 )
=-3780.136/( ( 4585.787 + 4352.406 )/ 2 )
=-3780.136/4469.0965
=-84.58 %

where Working Capital is:

Working Capital(Q: May. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1392.348 + 1950.413 + 171.175) - (2277.799 + 0 + 0)
=1236.137

Working Capital(Q: Aug. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1472.755 + 1993.873 + 179.099) - (2322.365 + 0 + 0)
=1323.362

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Aug. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Rite Aid's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Aug. 2023 )
=-1391.678/6496.838
=-21.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rite Aid EBIT Related Terms

Thank you for viewing the detailed overview of Rite Aid's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Rite Aid (Rite Aid) Business Description

Traded in Other Exchanges
Address
1200 Intrepid Avenue, PO Box 3165, Philadelphia, PA, USA, 17105
Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.
Executives
Christopher W. Dupaul officer: Chief Operating Officer 1200 INTREPID AVENUE, 2ND FLOOR, PHILADELPHIA PA 19112
Sabatino Thomas J Jr officer: Chief Legal Officer C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015
Steven Bixler officer: Chief Accounting Officer C/O RITE AID CORPORATION, 30 HUNTER LANE, CAMP HILL PA 17011
Heyward R Donigan officer: Chief Executive Officer 452 DISCOVERY ROAD, VIRGINIA BEACH VA 23451
Jocelyn Z Konrad officer: Executive VP RITE AID CORPORATION, 30 HUNTER LANE, CAMP HILL PA 17011
Ray Smithberger officer: SVP, Operations 30 HUNTER LANE, CAMP HILL PA 17011
Bari A Harlam director C/O MOHAWK GROUP HOLDINGS, INC., 37 EAST 18TH STREET, 7TH FLOOR, NEW YORK NY 10003
Paul D Gilbert officer: EVP, Secretary&General Counsel 103 POWELL COURT, SUITE 200, BRENTWOOD TN 37027
Andre Persaud officer: EVP, Retail 30 HUNTER LANE, CAMP HILL PA 17011
Dan Robson officer: President, EnvisionRXOptions 30 HUNTER LANE, CAMP HILL PA 17011
James J Peters officer: Chief Operating Officer C/O NXSTAGE MEDICAL, INC., 350 MERRIMACK STREET, LAWRENCE MA 01843
James J Comitale officer: EVP, General Counsel, Secy. 30 HUNTER LANE, CAMP HILL PA 17011
Jessica Kazmaier officer: EVP, Chief HR Officer 30 HUNTER LANE, CAMP HILL PA 17011
Justin L. Mennen officer: EVP, Chief Information Officer 30 HUNTER LANE, CAMP HILL PA 17011
Katherine B Quinn director US BANCORP, 800 NICOLLET MALL, MINNEAPOLIS MN 55402